GKGerrit Luit Ten Kate

Gerrit Luit Ten Kate

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gerrit Luit Ten Kate has a total of 169 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Precautionary Health Behaviours as Potential Confounders in COVID-19 Vaccine Effectiveness Studies

    by Chloé Wyndham-Thomas, Leonie de Munter, Kok Yew Ngew, Sanskruti Gaikwad, Konstantina Chatzikonstantinidou, Antonio Carmona, Charlotte Martin, Gerrit Luit Ten Kate, Nicolas Praet, Wilhelmine Meeraus, et al.

    Background/Objectives: Precautionary health behaviours (PHBs), such as hand-washing or self-isolation, are non-pharmaceutical interventions used to reduce SARS-CoV-2 transmission. We investigated the potential confounding by PHBs of COVID-19 vaccine effectiveness (VE) estimates in a subset of study participants enrolled in id.DRIVE. Methods: The id.DRIVE COVID-19 VE study (formerly COVIDRIVE) is a European multicentre test-negative case–control study estimating COVID-19 VE against hospitalisation due to laboratory-confirmed SARS-CoV-2 in patients with severe acute respiratory infection. All adults (≥18 y) prospectively enrolled between 16 November 2021 and 16 August 2023 at three sites were invited to complete a PHB survey capturing indicators of PHBs in the 3 months preceding admission. Fisher’s exact test with Bonferroni-adjusted threshold was used to measure the level of association between PHB indicators and both COVID-19 vaccine status and SARS-CoV-2 test result. VE estimates were generated with and without adjustment for PHBs. Results: PHBs were modified over time, with higher precautionary attitudes in the first COVID-19 vaccine booster season (2021–2022) compared to the second one (2022–2023). For the first booster season, PHBs were positively associated with exposures (vaccination status) and outcomes (case or control status). Adjusting for PHBs led to a 6 to 9 percentage-point increase in VE estimates. Conversely, no confounding by PHBs was observed in the second booster season. Conclusions: PHBs should be considered a possible confounder of COVID-19 VE studies. Further research is needed to define when PHBs should be integrated into VE models, as the level of confounding may differ according to the study population and the epidemiological context.


  • Open Access

    Vaccine effectiveness of JCOVDEN single-dose against COVID-19 hospitalisation in Europe: An id.DRIVE test-negative case-control study

    by Chloé Wyndham-Thomas, E. Claire Newbern, Ainara Mira-Iglesias, Akshat Dwivedi, Alejandro Orrico Sánchez, Andrés Antón, Charlotte Martin, Giancarlo Icardi, Irma Casas, Kok Yew Ngew, et al.


  • Open Access

    Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform

    by Jennifer L. Nguyen, Marianna Mitratza, Hannah R. Volkman, Leonie de Munter, Thao Mai Phuong Tran, Catia Marques, Mustapha Mustapha, Srinivas Valluri, Jingyan Yang, Andrés Antón, et al.


  • Follow-up blood cultures in Staphylococcus aureus bacteremia: a probability-based optimization

    by Sam Van Goethem, Hélène Boogaerts, Matthias Cuykx, Pol van Den Bremen, Kristien Wouters, Herman Goossens, Hilde Jansens, Gerrit Luit Ten Kate

    Staphylococcus aureus bacteremia (SAB) is a relevant finding which prompts a thorough diagnostic work-up. Follow-up blood cultures (BC) are essential in this work-up. We investigate the probability of detecting an ongoing bacteremia after initiation of active therapy according to the number of BC taken at key time points. A retrospective analysis of all patients with SAB in a 6-year period was performed. Total number of BCs taken and the positivity was registered for each day after start of therapy. A positivity-rate was corrected using a logistic mixed effects model. Observed detection frequencies were applied to calculate detection probabilities using binomial distributions. Three hundred and seventeen cases were withheld for analysis. A BC bottle positivity rate of 66.7% was found 1 day after initiation of active therapy, which decreased to 48.5% on day 4. When using 1 set of FU-BC, 73.4% of persisting SABs are detected. To maintain a probability of detection of ≥ 90%, 2 BC sets should be taken on day 2 and day 4 after start of therapy. In 10 of 109 patients with positive FU-BC, skip phenomena were registered, with a significant higher proportion in patients with < 4 BC bottles taken (14%) than when ≥ 4 BC bottles were taken (4.1%). We recommend taking 2 BC sets on days 2 and 4 after start of therapy in order to detect ≥ 90% of persisting SABs, limiting skip phenomena and blood volume required. We strongly advice against taking a single BC set as follow-up for SAB.


  • Open Access

    Two Cases of Post-Traumatic Mucormycosis due to Mucor circinelloides: Salvage Therapy with a Combination of Adjunctive Therapies

    by A. De Paepe, K. Dams, D. Robert, R. Jacobs, G. L. Ten Kate, S. Van Ierssel, H. Jansens, M. Lammens, A. Van Beeck, P. G. Jorens

    Mucormycosis is a rare, emerging angioinvasive infection caused by ubiquitous filamentous fungi. In recent decades, an increase in cutaneous or post-traumatic mucormycosis has been reported. We describe two cases of post-traumatic wound infections with Mucor circinelloides, a mucor species only rarely reported as a cause of post-traumatic mucormycosis. Often considered lethal, management required a combination of medical and surgical therapies to achieve a favorable outcome in both cases.


  • Contact allergy mimicking trench foot infection: a case study

    by Jonas De Leeuw, Michelle Mertens, An Bervoets, Gerrit Luit Ten Kate

    Hard-to-heal wounds are a major cause of morbidity and/or mortality. Multiple aetiologies can be identified and wounds can be treated according to their aetiology and macroscopic appearance. However, evidence behind the wide range of locally applied treatments is weak, without clear guidelines available to treat a variety of wound aetiologies. We present the case of a 63-year-old male with hard-to-heal wounds not responding to standard topical treatment. No clear underlying aetiology could be found. Extensive contact allergies were diagnosed after multiple topical and systemic treatments had been applied. A full recovery was observed after stopping topical agents and treating the wounds with an alternative treatment based on epicutaneous test results.


  • Quantitative Contrast-Enhanced Ultrasound of Intraplaque Neovascularization in Patients with Carotid Atherosclerosis

    by S. C. H. van Den Oord, Z. Akkus, J. G. Bosch, A. Hoogi, G. L. Ten Kate, G. Renaud, E. J. G. Sijbrands, H. J. Verhagen, A. van der Lugt, D. Adam, et al.

    Purpose: Intraplaque neovascularization (IPN) is an increasingly studied marker of the vulnerable atherosclerotic plaque, and contrast-enhanced ultrasound (CEUS) is an in vivo imaging technique for the assessment of IPN. The purpose of this study was to test novel quantification methods for the detection of carotid IPN using CEUS. Materials and Methods: 25 patients with established carotid atherosclerosis underwent bilateral carotid CEUS using a Philips iU-22 ultrasound system with an L9 – 3 transducer. Visual scoring of IPN was performed using a 3-point score. Quantification of IPN was performed using novel custom developed software. In short, regions of interest were drawn over the atherosclerotic plaques. After motion compensation, several IPN features were calculated. Statistical analysis was performed using Spearman’s rho. Reproducibility of the quantification features was calculated using intra-class correlation coefficients and mean differences between calculations. Results: 45 carotid arteries were available for the quantification of IPN. The quantification of IPN was feasible in all 45 carotid plaques. The IPN area, IPN area ratio and neovessel count had a good correlation with the visual IPN score (respectively ρ = 0.719, ρ = 0.538, ρ = 0.474 all p < 0.01). The intra-observer and inter-observer agreement was good to excellent (p < 0.01). The intra-observer and inter-observer variability was low. Conclusion: The quantification of carotid IPN on CEUS is feasible and provides multiple features on carotid IPN. Accurate quantitative assessment of IPN may be important to recognize and to monitor changes during therapy in vulnerable atherosclerotic plaques. Ziel: Die Intraplaque-Neovaskularisation (IPN) ist ein in zunehmendem Maße untersuchter Parameter bei einer vulnerablen artherosklerotischen Plaque und der kontrastverstärkte Ultraschall (CEUS) dient als bildgebendes Verfahren für die in-vivo-Bewertung der Karotis-IPN. Das Studienziel bestand in der Austestung neuer Quantifizierungsmethoden beim Nachweis einer Karotis-IPN mittels CEUS. Material und Methoden: An 25 Patienten mit bestätigter Atherosklerose der Halsschlagader wurde ein bilateraler Karotis-CEUS mit dem Philips iU-22 Ultraschallsystem und einem L9–3-Schallkopf durchgeführt. Die visuelle IPN-Bewertung wurde mit einer 3-Punkte-Skala durchgeführt. Die Quantifizierung der IPN erfolgte mit einer neuartigen, maßgeschneiderten kundenspezifischen Software. In Kürze zusammengefasst wurden „Regions of Interest“ über die artherosklerotischen Plaques gezogen. Nach der Bewegungskompensation wurden verschiedene IPN-Parameter berechnet. Die statistische Analyse erfolgte mit dem Spearmans-Rangkorrelationskoeffizienten. Die Reproduzierbarkeit der Quantifikationsparameter wurde durch Intraklasse-Korrelationskoeffizienten und durch die mittleren Differenzen zwischen den Kalkulationen errechnet. Ergebnisse: Für die Quantifizierung der IPN standen 45 Halsschlagadern zur Verfügung. Die IPN-Quanifizierung war in allen 45 Karotisplaques durchführbar. Die Übereinstimmung der visuellen IPN-Bewertung mit der IPN-Fläche (ρ = 0,719), der IPN-Flächen-Ratio (ρ = 0,538) und der Anzahl der Neugefäße (ρ = 0,474) war gut (jeweils p < 0,01). Die Intraobserver- und Interobserver-Übereinstimmung war gut bis ausgezeichnet (p < 0,01). Die Intraobserver- und Interobserver-Variabilität war niedrig. Schlussfolgerung: CEUS ermöglicht die quantitative Analyse von Karotis-IPNs und bestimmt mehrere Merkmale der Neovaskularisation von artherosklerotischen Karotis-Plaques. Eine präzise quantitative Analyse der IPN kann therapiebegleitend für die Erkennung und die Überwachung von Veränderungen vulnerabler artherosklerotischer Plaques von Bedeutung sein.


  • New Quantification Methods for Carotid Intra-plaque Neovascularization Using Contrast-Enhanced Ultrasound

    by Zeynettin Akkus, Assaf Hoogi, Guillaume Renaud, Stijn C.H. van Den Oord, Gerrit L. Ten Kate, Arend F.L. Schinkel, Dan Adam, Nico de Jong, Antonius F.W. van der Steen, Johan G. Bosch


  • Usefulness of Contrast-Enhanced Ultrasound for Detection of Carotid Plaque Ulceration in Patients With Symptomatic Carotid Atherosclerosis

    by Gerrit L. Ten Kate, Anouk C. van Dijk, Stijn C.H. van Den Oord, Burhan Hussain, Hence J.M. Verhagen, Eric J.G. Sijbrands, Antonius F.W. van der Steen, Aad van der Lugt, Arend F.L. Schinkel


  • Top Cited Papers

    Carotid intima-media thickness for cardiovascular risk assessment: Systematic review and meta-analysis

    by Stijn C.H. van Den Oord, Eric J.G. Sijbrands, Gerrit L. Ten Kate, David van Klaveren, Ron T. van Domburg, Antonius F.W. van der Steen, Arend F.L. Schinkel